Progress and Obstacles in the Application of Precision Medicine in the Management of Hepatocellular Carcinoma

E-ISSN： 2212-6988|4|2|129-134

ISSN： 2212-697x

Source： Clinical Cancer Drugs, Vol.4, Iss.2, 2018-01, pp. : 129-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contemporary management of hepatocellular carcinoma

By Palmer Daniel

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 442-447

Royal College Of Physicians

Access to resources Recommend Favorite

Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

By Guan Yong-Song He Qing

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 303-313

Informa Healthcare

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Herbal Medicine on High Impact Disease: The Current Progress and Application

Current Pharmaceutical Design, Vol. 23, Iss. 34, 2018-01 ,pp. : 5075-5076

Bentham Science Publishers

Access to resources Recommend Favorite